# Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects

> **NCT05902728** · PHASE1 · COMPLETED · sponsor: **Shanghai Henlius Biotech** · enrollment: 20 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** HLX208
- **DRUG:** HLX208
- **DRUG:** HLX208
- **DRUG:** HLX208
- **DRUG:** Itraconazole 200 mg
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT05902728
- **Lead sponsor:** Shanghai Henlius Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-04
- **Primary completion:** 2023-12-19
- **Final completion:** 2023-12-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05902728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05902728, "Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT05902728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*